IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jean, M. D. S.
Right arrow Articles by Baudouin, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jean, M. D. S.
Right arrow Articles by Baudouin, C.
(Investigative Ophthalmology and Visual Science. 2000;41:2531-2543.)
© 2000 by The Association for Research in Vision and Ophthalmology, Inc.

Fas- and Interferon {gamma}-Induced Apoptosis in Chang Conjunctival Cells: Further Investigations

Magdalena De Saint Jean1,2, Caroline Debbasch3, Mohamed Rahmani2, Françoise Brignole4, Gérard Feldmann2, Jean-Michel Warnet3 and Christophe Baudouin1

1 From the Services d’Ophthalmologie et 2 d’Immunohématologie, Hôpital Ambroise Paré, AP-HP, Université René Descartes Paris V, Boulogne, France; 3 Laboratoire de Biologie Cellulaire, INSERM U327, Faculté de Médecine Xavier Bichat, Université Paris VII, Paris, France; and 4 Service de Pharmacotoxicologie, Centre Hospitalier National d’Ophtalmologie XV-XX, Paris, France.

PURPOSE. Previously interferon (IFN){gamma}-induced apoptosis and expression of inflammation-related proteins in a human conjunctival cell line were demonstrated. The aim of this study was to further investigate the mechanisms of IFN{gamma}-, Fas-, and cycloheximide (CHX)-induced programmed cell death, with special attention to the role of transcriptional factors NF-{kappa}B and STAT1.

METHODS. In a human conjunctival cell line (Chang conjunctival cells) apoptosis was induced with 500 ng/ml anti-Fas antibody (anti-Fas ab) alone (24 or 48 hours) or, as previously reported, with 300 U/ml of human recombinant IFN{gamma} alone (48 hours). To study the role of IFN{gamma} on Fas-induced apoptosis, cells were treated first with IFN{gamma} at 30 U/ml during 24 hours (nontoxic dose), and then anti-Fas ab was applied for 24 hours. Moreover, to study the influence of CHX on Fas- and IFN{gamma}-induced apoptosis, cells were treated for 24 hours with 300 U/ml IFN{gamma} together with a nontoxic concentration (1 µg/ml) of CHX, or with 500 ng/ml anti-Fas ab together with 1 µg/ml CHX (24 hours). After treatment, cell viability (neutral red assay), mitochondrial membrane potential (rhodamine 123 assay), chromatin condensation (Hoechst 33342 assay), and the index Hoechst/neutral red were studied by cold light microplate cytometry. The apoptotic process was sought for by contrast phase microscopy and DAPI staining and was confirmed by immunoblotting of PARP. Activation of caspase-3 (CPP32) and caspase-8 were investigated by Western blot analysis. NF-{kappa}B and STAT DNA-binding activities were studied by electrophoretic mobility shift assays (EMSA).

RESULTS. After 24 and 48 hours of treatment with anti-Fas ab alone, 15% to 20% and 30%, respectively, of apoptotic cells were observed. When anti-Fas sera were applied after IFN{gamma} pretreatment or together with CHX, 50% to 80% of cells demonstrated morphologic characteristics of programmed cell death. Apoptosis was confirmed by a cleavage of PARP and CPP32, by caspase-8 activation, and by an index Hoechst/neutral red greater than one. All these modifications were preceded by a decrease in mitochondrial membrane potential. EMSA revealed that NF-{kappa}B was activated after IFN{gamma} and anti-Fas ab treatments and inhibited after CHX treatment. STAT1 was strongly activated after IFN{gamma} treatment and only in a minor degree after anti-Fas ab treatment. STAT1-binding activity persisted after CHX treatment.

CONCLUSIONS. The relative resistance of Chang cells toward Fas-induced apoptosis could be related to the activation of NF-{kappa}B. IFN{gamma}-induced programmed cell death preferentially involves the activation of STAT1 that counterbalances NF-{kappa}B antiapoptotic effects. In fact, Fas-induced apoptosis was potentiated by IFN{gamma} or CHX treatments. These results suggest that NF-{kappa}B activation could maintain cell viability as well as participate in IFN{gamma}-induced inflammatory modifications, whereas STAT1 activation could provide, in this model, a proapoptotic signal.




This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
M. Krzyzowska, M. Polanczyk, M. Bas, J. Cymerys, A. Schollenberger, F. Chiodi, and M. Niemialtowski
Mousepox conjunctivitis: the role of Fas/FasL-mediated apoptosis of epithelial cells in virus dissemination
J. Gen. Virol., July 1, 2005; 86(7): 2007 - 2018.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
N. Awasthi and B. J. Wagner
Interferon-{gamma} Induces Apoptosis of Lens {alpha}TN4-1 Cells and Proteasome Inhibition Has an Antiapoptotic Effect
Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 222 - 229.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
Y. Diebold, M. Calonge, A. E. de Salamanca, S. Callejo, R. M. Corrales, V. Saez, K. F. Siemasko, and M. E. Stern
Characterization of a Spontaneously Immortalized Cell Line (IOBA-NHC) from Normal Human Conjunctiva
Invest. Ophthalmol. Vis. Sci., October 1, 2003; 44(10): 4263 - 4274.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. Narayanan, W. L. Miller, and A. M. McDermott
Expression of Human {beta}-Defensins in Conjunctival Epithelium: Relevance to Dry Eye Disease
Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3795 - 3801.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the Association for Research in Vision and Ophthalmology